Bolt Biotherapeutics Stock Analysis

Bolt Stock Analysis Notes

About 48.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.23. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bolt Biotherapeutics recorded a loss per share of 1.71. The entity last dividend was issued on the August 29, 2014. The firm had 3:2 split on the January 31, 2008. Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California. Bolt Biotherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 91 people. For more info on Bolt Biotherapeutics please contact Randall Schatzman at 650 665 9295 or go to https://www.boltbio.com.

Bolt Biotherapeutics Investment Alerts

Bolt Biotherapeutics Upcoming and Recent Events

Bolt Largest EPS Surprises

View All Earnings Estimates

Bolt Stock Institutional Investors

Note, although Bolt Biotherapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bolt Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.75 M.

Bolt Profitablity

Management Efficiency

Bolt Biotherapeutics has return on total asset (ROA) of (0.3176) % which means that it has lost $0.3176 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6499) %, meaning that it created substantial loss on money invested by shareholders. Bolt Biotherapeutics' management efficiency ratios could be used to measure how well Bolt Biotherapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.67 in 2025. Return On Capital Employed is likely to drop to -0.92 in 2025. Non Current Liabilities Total is likely to gain to about 46.8 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 16.1 M in 2025.

Technical Drivers

As of the 25th of March, Bolt Biotherapeutics shows the Risk Adjusted Performance of (0.04), standard deviation of 3.51, and Mean Deviation of 2.59. Bolt Biotherapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Bolt Biotherapeutics Price Movement Analysis

Bolt Biotherapeutics Insider Trading Activities

Bolt Biotherapeutics Outstanding Bonds

Bolt Biotherapeutics Predictive Daily Indicators

Bolt Biotherapeutics Forecast Models

Bolt Biotherapeutics' time-series forecasting models are one of many Bolt Biotherapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bolt Biotherapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bolt Biotherapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bolt shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bolt Biotherapeutics. By using and applying Bolt Stock analysis, traders can create a robust methodology for identifying Bolt entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bolt analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bolt analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Bolt Biotherapeutics stock analysis indicators help investors evaluate how Bolt Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bolt Biotherapeutics shares will generate the highest return on investment. By understating and applying Bolt Biotherapeutics stock analysis, traders can identify Bolt Biotherapeutics position entry and exit signals to maximize returns.

When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.